Hyderabad, Jul 20 (UNI) Dr. Reddy’s Laboratories Ltd. along with its subsidiaries together referred to as “Dr. Reddy’s on Friday announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP,
20 mg, an over-the-counter (OTC) therapeutic equivalent generic version of Nexium 24HR Capsules in the United States market.
The capsules were approved by the U.S. Food and Drug Administration (USFDA), the Hyderabad-based pharmacautical company said in a release here.
Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days a week in adults.
This launch continues to demonstrate our deep R&D and manufacturing capabilities to bring newer store-brand
OTC medications to the market,” Milan Kalawadia, Vice President and Head, US OTC and Speciality Rx businesses, Dr. Reddy’s Laboratories said.
We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers, Mr Milan said.
The combined market of Nexium 24HR Capsules and private label OTC Esomeprazole Magnesium products had U.S. sales of approximately $311 million for the most recent 12 months ending in May 2018, the release said.
UNI KNR CS 1145